S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
pixel
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
pixel
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
pixel
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
pixel
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
NYSE:GSK

GSK - GSK Stock Forecast, Price & News

$40.57
-0.03 (-0.07%)
(As of 08/5/2022 05:40 PM ET)
Add
Compare
Today's Range
$40.07
$40.63
50-Day Range
$40.22
$44.97
52-Week Range
$37.80
$46.97
Volume
3.82 million shs
Average Volume
4.76 million shs
Market Capitalization
$82.51 billion
P/E Ratio
13.43
Dividend Yield
4.12%
Price Target
N/A

GSK MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.28% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.31mentions of GSK in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.25%
From $3.43 to $3.61 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.51 out of 5 stars

Medical Sector

179th out of 1,283 stocks

Pharmaceutical Preparations Industry

73rd out of 615 stocks

GSK stock logo

About GSK (NYSE:GSK) Stock

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Analysts Set New Price Targets

Several research analysts have recently commented on GSK shares. StockNews.com started coverage on GSK in a report on Thursday, July 28th. They issued a "strong-buy" rating on the stock. JPMorgan Chase & Co. boosted their price objective on shares of GSK from GBX 1,740 ($21.32) to GBX 1,900 ($23.28) in a research report on Thursday, April 28th. Barclays boosted their price objective on shares of GSK from GBX 1,775 ($21.75) to GBX 1,800 ($22.06) in a research report on Friday, April 29th. Morgan Stanley restated an "equal weight" rating on shares of GSK in a research report on Friday. Finally, UBS Group dropped their price objective on shares of GSK from GBX 1,876 ($22.99) to GBX 1,850 ($22.67) in a research report on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, GSK currently has a consensus rating of "Hold" and an average target price of $1,787.50.

GSK Trading Down 0.1 %

Shares of GSK Stock traded down $0.03 on Friday, hitting $40.57. 3,819,867 shares of the company's stock traded hands, compared to its average volume of 4,762,247. The firm's 50-day moving average price is $42.59 and its two-hundred day moving average price is $43.48. The stock has a market capitalization of $82.51 billion, a PE ratio of 13.43, a price-to-earnings-growth ratio of 1.45 and a beta of 0.46. GSK has a one year low of $37.80 and a one year high of $46.97. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.43 and a quick ratio of 1.31.

GSK Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 6th. Shareholders of record on Friday, August 19th will be given a dividend of $0.383 per share. This is a boost from GSK's previous quarterly dividend of $0.35. The ex-dividend date is Thursday, August 18th. This represents a $1.53 annualized dividend and a dividend yield of 3.78%. GSK's payout ratio is presently 55.30%.

Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Stock News Headlines

GSK plc (NYSE:GSK) Short Interest Update
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Watch These 4 Penny Stocks…
Small cap stocks – and penny stocks in particular – tend to march to the beat of their own drummer. Low-priced, “penny,” stocks like these offer a great way to make money regardless of the direction of the markets as a whole… Click here to see how you can get the names & ticker symbols of all four penny stocks. pixel
GSK (NYSE:GSK) Rating Reiterated by Citigroup
GSK (NYSE:GSK) Price Target Cut to GBX 1,850
GSK (NYSE:GSK) Downgraded by AlphaValue to "Reduce"
Why GlaxoSmithKline Stock Jumped 25% on Thursday
See More Headlines
Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Company Calendar

Last Earnings
2/02/2021
Ex-Dividend for 7/1 Dividend
5/19/2022
Dividend Payable
7/01/2022
Today
8/07/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Employees
90,096
Year Founded
2000

Profitability

Net Income
$6.03 billion
Pretax Margin
16.84%

Debt

Sales & Book Value

Annual Sales
$46.91 billion
Cash Flow
$3.62 per share
Book Value
$13.98 per share

Miscellaneous

Outstanding Shares
2,033,680,000
Free Float
1,830,309,000
Market Cap
$82.51 billion
Optionable
Optionable
Beta
0.46

Social Links


Key Executives

  • Ms. Emma N. Walmsley (Age 52)
    CEO & Director
    Comp: $4.59M
  • Mr. Iain James Mackay (Age 60)
    CFO & Exec. Director
    Comp: $3.41M
  • Dr. Hal V. Barron F.A.C.C. (Age 59)
    M.D., Chief Scientific Officer, Pres of R&D and Director
    Comp: $6.16M
  • Ms. Shobie Ramakrishnan
    Chief Digital & Technology Officer
  • Ms. Sarah Elton-Farr
    Head of Investor Relations
  • Mr. James Ford
    Sr. VP & Group Gen. Counsel of Legal & Compliance
  • Ms. Sally Jackson
    Sr. VP of Global Communications & CEO Office
  • Ms. Diana Conrad
    Chief People Officer
  • Mr. David Simon Redfern (Age 56)
    Chief Strategy Officer
  • Mr. Philip C. Thomson
    Pres of Global Affairs













GSK Stock - Frequently Asked Questions

Should I buy or sell GSK stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GSK in the last year. There are currently 1 sell rating, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GSK stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View analyst ratings for GSK
or view top-rated stocks.

How has GSK's stock price performed in 2022?

GSK's stock was trading at $44.10 at the beginning of 2022. Since then, GSK shares have decreased by 8.0% and is now trading at $40.57.
View the best growth stocks for 2022 here
.

Are investors shorting GSK?

GSK saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 5,570,000 shares, a decrease of 16.7% from the June 30th total of 6,690,000 shares. Based on an average daily volume of 4,580,000 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.3% of the company's stock are short sold.
View GSK's Short Interest
.

When is GSK's next earnings date?

GSK is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our earnings forecast for GSK
.

How were GSK's earnings last quarter?

GSK plc (NYSE:GSK) posted its earnings results on Tuesday, February, 2nd. The pharmaceutical company reported $0.62 EPS for the quarter, missing analysts' consensus estimates of $0.64 by $0.02. The pharmaceutical company had revenue of $8.74 billion for the quarter, compared to analyst estimates of $8.71 billion. GSK had a trailing twelve-month return on equity of 27.84% and a net margin of 12.91%. GSK's revenue was down 1.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.39 earnings per share.
Read GSK's conference call transcript
.

How often does GSK pay dividends? What is the dividend yield for GSK?

GSK declared a quarterly dividend on Wednesday, July 27th. Shareholders of record on Friday, August 19th will be paid a dividend of $0.383 per share on Thursday, October 6th. This represents a $1.53 dividend on an annualized basis and a yield of 3.78%. The ex-dividend date is Thursday, August 18th. This is a positive change from GSK's previous quarterly dividend of $0.35.
View GSK's dividend history
.

Is GSK a good dividend stock?

GSK(NYSE:GSK) pays an annual dividend of $1.67 per share and currently has a dividend yield of 4.12%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of GSK is 55.30%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GSK will have a dividend payout ratio of 46.26% next year. This indicates that GSK will be able to sustain or increase its dividend.
View GSK's dividend history.

What guidance has GSK issued on next quarter's earnings?

GSK issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $49.73 billion-$50.67 billion, compared to the consensus revenue estimate of $38.72 billion.

What other stocks do shareholders of GSK own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GSK investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), Walt Disney (DIS) and NVIDIA (NVDA).

What is GSK's stock symbol?

GSK trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

Who are GSK's major shareholders?

GSK's stock is owned by a number of retail and institutional investors. Top institutional investors include JTC Employer Solutions Trustee Ltd (0.43%), Douglas Lane & Associates LLC (0.07%), Connor Clark & Lunn Investment Management Ltd. (0.06%), Russell Investments Group Ltd. (0.05%), National Bank of Canada FI (0.03%) and Kornitzer Capital Management Inc. KS (0.03%).
View institutional ownership trends for GSK
.

How do I buy shares of GSK?

Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GSK's stock price today?

One share of GSK stock can currently be purchased for approximately $40.57.

How much money does GSK make?

GSK (NYSE:GSK) has a market capitalization of $82.51 billion and generates $46.91 billion in revenue each year. The pharmaceutical company earns $6.03 billion in net income (profit) each year or $3.02 on an earnings per share basis.

How many employees does GSK have?

GSK employs 90,096 workers across the globe.

When was GSK founded?

GSK was founded in 2000.

How can I contact GSK?

GSK's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The official website for GSK is www.gsk.com. The pharmaceutical company can be reached via phone at 442080475000, via email at gsk.investor-relations@gsk.com, or via fax at 44-20-8047-7807.

This page (NYSE:GSK) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.